| Target Price | $183.60 |
| Price | $140.16 |
| Potential |
30.99%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target ICU Medical, Inc. 2026 .
The average ICU Medical, Inc. target price is $183.60.
This is
30.99%
register free of charge
$194.25
38.59%
register free of charge
$154.53
10.25%
register free of charge
|
|
| A rating was issued by 12 analysts: 10 Analysts recommend ICU Medical, Inc. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the ICU Medical, Inc. stock has an average upside potential 2026 of
30.99%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 2.38 | 2.24 |
| 5.44% | 6.13% | |
| EBITDA Margin | 4.36% | 17.55% |
| 51.41% | 302.13% | |
| Net Margin | -4.94% | 7.87% |
| 276.32% | 259.29% |
9 Analysts have issued a sales forecast ICU Medical, Inc. 2025 . The average ICU Medical, Inc. sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an ICU Medical, Inc. EBITDA forecast 2025. The average ICU Medical, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 ICU Medical, Inc. Analysts have issued a net profit forecast 2025. The average ICU Medical, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -4.83 | 7.13 |
| 292.68% | 247.62% | |
| P/E | 19.66 | |
| EV/Sales | 2.01 |
9 Analysts have issued a ICU Medical, Inc. forecast for earnings per share. The average ICU Medical, Inc. EPS is
This results in the following potential growth metrics and future valuations:
ICU Medical, Inc....
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Piper Sandler |
Locked
➜
Locked
|
Locked | Nov 07 2025 |
| Keybanc |
Locked
➜
Locked
|
Locked | Nov 07 2025 |
| Keybanc |
Locked
➜
Locked
|
Locked | Oct 21 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Sep 10 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 15 2025 |
| Raymond James |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
| Raymond James |
Locked
➜
Locked
|
Locked | May 09 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Nov 07 2025 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Nov 07 2025 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Oct 21 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Sep 10 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 15 2025 |
|
Locked
Raymond James:
Locked
➜
Locked
|
Aug 08 2025 |
|
Locked
Raymond James:
Locked
➜
Locked
|
May 09 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


